|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 161 - 170 of 465:
McAfee Redefines Security and Compliance Management
McAfee announced availability of McAfee ePolicy Orchestrator 4.0 (ePO), the first and only platform that lets enterprises and governments, centrally m...
Nanosphere Announces First FDA Cleared Genetic Test for Warfarin Sensitivity and Nanotechnology-based Molecular Diagnostics Platform
Nanosphere, nanotechnology-based molecular diagnostics company, announced that it has received clearance from the U.S. Food and Drug Administration (F...
St. Jude Medical Announces FDA Approval of Company’s First Radiofrequency Wireless ICD and CRT-D Heart Failure Devices
-St. Jude Medical, announced U.S. Food and Drug Administration (FDA) approval of its first radiofrequency (RF) wireless devices to treat patients with...
AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to...
FDA Advisory Committees Recommend Continued US Marketing Authorization for Trasylol
The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administrat...
FDA Approves LEVAQUIN Short-Course Therapy for Treatment of Complicated UTI
The U.S. Food and Drug Administration (FDA) has approved use of the five-day, once-daily regimen of LEVAQUIN (levofloxacin) 750 mg I.V. and oral, for ...
FDA Clears Genetic Lab Test for Warfarin Sensitivity
The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especia...
MedPointe's SOMA Gets FDA Approval
MedPointe Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved SOMA (carisoprodol) 250 mg as a new recommended dose of S...
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
Medtronic announced that a U.S. Food and Drug Administration (FDA) Advisory Panel will review the Premarket Approval (PMA) application for the company...
VMware Introduces Next-Generation Disaster Recovery with VMware Site Recovery Manager
VMware announced VMware Site Recovery Manager, a pioneering new product for disaster recovery automation. The new software will be among the many prod... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |